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Colorectal cancer (CRC) is the most prevalent and 
incident cancers worldwide and a main cause of 
cancer-related death in western countries (1). It is a 
very heterogeneous disease that is caused by the 
interaction of genetic and environmental factors and 
can be classified based on the importance of each of  
 Mesenchymal Stem Cells (MSCs) are self-renewing multipotent 
cells that can be isolated from various organs including Wharton’s 
jelly of umbilical cord (WJMSCs). WJMSCs play a fundamental 
role in field of regenerative medicine and hold therapeutic potential 
for various diseases including gene therapy of different cancers. 
WJMSCs were evaluated for their potential behavior in cancer 
conditions by culturing them in the plasma obtained from colorectal 
cancer patients. The cancer plasma was tested LDH release, 
paracrine factors (p53, p38, BAX and BCl2) and oxidative stress. 
Cell viability, death and proliferation was assessed by crystal violet 
staining, LDH release and MTT assay respectively. Assessment of 
cancer plasma expressed high LDH release, low expression of pro-
apoptotic gene BAX, high expression of survival gene BCl2 p38 
kinase and tumor suppressor gene p53. In oxidative stress, GSH and 
SOD were increased in CRC. In CAT, it was highly expressed in 
CRC. Furthermore, increased level of MDA was expressed in 
cancers’ plasma. It was observed that cells cultured in plasma of 
cancer  demonstrate less viability, low proliferation rate, high LDH 
release, low expression of BAX and p38 kinase, whereas, high 
expression of BCL2 and p53. In oxidative stress, low GSH, SOD, 
CAT and high MDA was observed in CRC.When WJMSCs 
cultured in plasma from colorectal cancer patients these cells show 
reduced viability, proliferation and increased apoptosis. For the 
future, certain measures should be taken to improve viability of 
WJMSCs in cancer conditions.   
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these factors (2) also CRC cases could be avoided 
with a healthy lifestyle (3). In colon epithelial 
cells, changes in genetic and epigenetic leads to 
malignant tumor originating in glandular 
epithelium (4) its survival rate is 5 years. It 
further include growth of cancer in the colon, 
appendix and rectum (5). Mostly, CRCs are arises 
from adenomatous polyps located in colon which 
can be removed before they become cancerous (6). 
Treatment such as radio and chemotherapy, are 
employed to CRC and a various researchers have 
identified prognosticative factors. Still, complete 
remedy of CRC has not been full filled in contempt 
to limitless efforts (7). 
The common causes for CRC includes, less use of fruit 
and vegetables, excessive intake of red meat and 
saturated fat, alcohol intake, male gender, smoking,  a 
sedentary life-style, tobacco, use of drugs, body mass 
index and being overweight. Age is also the main risk 
factor it is more frequent in 50 onwards and this risk is 
directly proportional age (8-10).  
Colonoscopy is considered the standard tool for the 
diagnosis of colorectal pathologies and use of 
postmenopausal hormone have been linked with 
reduced CRC risk (11, 12). Treatment of CRC consists 
of complete surgical removal of primary lesions and 
lymph nodes (13). The mutations and epigenetic 
alterations in CRC usually involved in the progression  
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are shown in Figure below. There are 5 stages of 
this disease. Stage 0 during formation of an early 
adenoma, stage I where the tumor is located in 
mucosal layer, stage II when it just penetrates the 
serosa followed by increasing angiogenesis, stage 
III when the cancer has spread to surrounding 
lymph nodes and finally stage IV with distal 
metastasis, the cancer has spread to other organs. 
MSCs are a type of heterogeneous cells that have 
the ability to self-renew, cells isolated majorly from 
bone marrow and other post-natal tissues and are 
multipotent cells. They can be easily isolated, have 
potential to migrate towards the inflammatory sites 
and can be therapeutically used in clinical studies to 
target tumors (14).  
MSCs derived from human umbilical cord is an 
extremely attractive source of SCS having great 
potentials in clinical applications and regenerative 
medicine. There are benefits to use UC stem cells 
because these cells are non-tumorigenic, highly 
proliferative, and less immunogenic and ethically 
approved (15). UC is an extremely rich source of 
SCs. WJMSCs have many potentials in 
comparison other SCs types (16). The UC 
comprises of two umbilical arteries and one 
umbilical vein, cord lining and Wharton's jelly 
(17). Stem cells obtained from UCB play a vital 
role as these cells gave a reduced rate of rejection 
after transplanting them into mismatched host and 
their potential to generate large amounts of 
homogeneous tissue or cells (18).  WJMSCs hold a 
great therapeutic potential for tissue repair and 
regeneration  in various in vitro studies of human 
diseases including cancer, heart problems, 
neurodegenerative disease, etc. (19). MSCs are 
attractive nominees for cell based therapies as till 
now human trials of MSCs show no inauspicious 
reactions towards MSC transplants (20). MSCs 
presents various approaches that makes them a 
perfect source of therapeutic agents in the field of 
regenerative medicine (21). 
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The aim of study was to evaluation the potential of 
Wharton's jelly mesenchymal stem cells in 
colorectal cancer. 
Materials and Methods  
Sample collection 
Blood samples of cancer patients were taken from 
INMOL (Institute of Nuclear Medicine and 
Oncology) hospital, Lahore. A total of 3-5 ml of 
blood sample was collected from each patient in 
heparinized vials. Plasma was isolated from these 
blood samples. Plasma samples were pooled of 3 
patients and passed through syringe filter (0.22µm) 
before storing aliquots at -20˚C.  Several tests were 
performed on blood from patients with CRC 
including hematology analysis, LDH assay, 
ELISA, catalase assay, estimation of oxidative 
stress, examination of glutathione, examination of 
sodium dodecyl sulphate, estimation of 
malondialdehyde.  
Furthermore, Human umbilical cords from normal 
full term caesarian sections without HCV, HBV 
and HIV infection were obtained from Social 
Security Hospital, Lahore. A 1 inch piece of human 
umbilical cord was taken in a 50 ml tube 
containing PBS (Phosphate Buffer Saline) with 
100U/ml penicillin and 100μg/ml streptomycin. 
LDH assay 
LDH is an enzyme used to measure cell membrane 
integrity. Normal and different cancer plasma were 
compared to evaluate LDH release. Cytotoxicity 
level was assessed by the lactate dehydrogenase 
assay (LDH) assay kit according to manufacturer’s 
instructions. Briefly, reagent was prepared by 
mixing R1 and R2 in a ratio of 4:1. 5 µL plasma 
and 95 µL reagent was added in single well of a 
microtiter plate. Absorbance was measured at a 
wavelength of 340 nm. 
ELISA 
Solid phase sandwich ELISA was performed for 
BCL-2, BAX, p53 and p38 (Invitrogen, USA). A 
microtiter plate (Corning, USA) was coated with 
primary antibodies i.e. mouse anti BCL-2, BAX 
and p53 and rabbit anti p38 and incubated for 48 
hours at 4°C. After washing thrice with TBS, 
100µL serum samples were loaded and incubated 
for 18 hours. The wells were then washed three 
times, blocked for 1 hour with 10% BSA leading to 
overnight incubation with secondary antibody i.e. 
HRP conjugated goat anti rabbit for p38 and HRP 
conjugated goat anti mouse for BCL-2, BAX and 
p53. After washing equal volume of chromogenic 
solution (TMB) and 0.1mM HCL was added, to 
stop the reaction. Using a microtiter plate reader, 
read the plate at the appropriate wavelength for the 
substrate at 450nm keeping 650nm as reference 
value. 
Estimation of glutathione 
100µl of plasma was taken, homogenate was 
prepared in 100µl (10%) TCA and centrifuged at 
1000 rpm for 10 minutes at 25˚C. In a microtiter 
plate, 40µl the supernatant was added with 150µl 
disodium phosphate buffer and 25µl DTNB. 
Incubated this plate for 15 minutes and absorbance 
was taken at 412 nm.  
 Estimation of sodium dodecyl sulphate 
50µl of plasma was taken, homogenate was 
prepared in 50µl (50%) TCA and centrifuged at 
13,000 rpm for 10 minutes at 25˚C. 15µl of the  
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supernatant was added to 120µl sodium 
pyrophosphate buffer (52mM) pH=8.3, 12µl 
phenazine methosulphate, 36µl NBT and reaction 
was started by addition of 24µl (NADH). After 
incubation at 37˚C for 90 seconds, the reaction was 
stopped by the addition of 12 µl of glacial acetic 
acid. The reaction mixture was stirred vigorously 
with 400µl of n-Butanol. The mixture was 
incubated for 10 minutes and then was centrifuged 
at 2000 rpm for 5 minutes at 25˚C. 200µl of 
butanol layer was taken in microtiter plate. 
Absorbance was observed at 560 nm. 
Catalase assay 
40µl plasma was taken, homogenate was prepared 
in 360µl phosphate buffer (10mM) pH=7.4, 
centrifuged at 13,000 rpm for 10 minutes at 25˚C. 
21µl supernatant and 180µl phosphate buffer 
(10mM) pH=7 were added in an eppendorf (1.5ml) 
tube. Reaction was started by addition of freshly 
prepared 75µl H2O2 (0.2M). 360µl potassium 
dichromate acetic acid reagent (5%) leading to 
incubation for 10 minutes in boiling water. 150µl 
of the mixture was added in a microtiter plate and 
absorbance was taken at 530 nm. 
Estimation of Malondialdehyde  
The levels of MDA were measured by using 
thiobarbituric acid reactive substances. 40 µl of 
plasma was taken and a homogenate was prepared 
in 360µl of 10 mM phosphate buffer (pH 7.4) and 
centrifuged at 13,000 rpm for 10 minutes at 25˚C. 
Concentration of MDA, a metabolite of 
polyunsaturated fatty acids, was assessed as a 
marker for lipid peroxidation. 15µl of the 
supernatant was added to 15µl SDS (8.1%), 96µl 
TBA (0.8%), 96µl Acetic Acid (20%) and 18µl 
distilled water and incubated at 90˚C for 60 
minutes. Afterwards 60µl distilled water, 300µl 
mixture of n-Butanol and pyridine with the ratio of 
15:1 was added and the mixture was shaken 
vigorously and centrifuged at 4000rpm at 25 °C for 
10 minutes. The thiobarbituric acid-reactive 
substances in the n-butanol layer 125µl were taken 
in a microtiter plate. Absorbance was taken at 532 
nm. 
Isolation and culturing of WJMSCS 
Samples were transferred to the laboratory and 
washed twice with PBS. The entire process was 
done in Class II BioSafety Cabinet under sterile 
conditions. Small piece of cord was minced 
thoroughly into very fine pieces. The pieces were 
transferred to a 25cm2 culture flasks (Sigma 
Aldrich, USA) with Dulbecco’s modified Eagle’s 
medium with low glucose (DMEM LG) and 10% 
Human Plasma, penicillin (100 units/ml) and 
streptomycin (100 µg/ml). The cells were then 
placed in the humidified incubator supplied with 
5% CO2 at 37
oC. After 72 hours medium was 
changed carefully and cells were fed with fresh 
medium thereafter. Non adherent cells were 
removed and replaced with fresh medium, 
observed culture under microscope to assess the 
degree of confluency. 
Sub culturing of WJMSCS 
Cells at 80-90% confluence were subjected to 
passage. Cells were dissociated using 1X Trypsin-
EDTA for 4-5 minutes at 37°C and 5% CO2 until 
the Cells began to detach. Detachment was 
confirmed by observing the flask under Phase 
contrast microscope, then neutralized with equal 
volume of complete culture medium. Cells were 
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plated in a 75 cm2 culture flasks and placed in 
incubator. Cells at passage 3 were used for further 
experiments. 
Characterization of WJMSCs 
The cultured cells were plated in a 6 welled plate 
for characterization by immunocytochemistry for 
24 hours. Media was removed and cells were 
washed with PBS (Invitrogen Inc., USA) three 
times for 5 minutes leading to fixation by 
incubating them in ice cold methanol for 20 
minutes. Cells were incubated with 1% BSA for 
30 minutes to block unspecific binding of the 
antibodies. Cells were Incubated with primary 
antibodies i.e. goat anti CD 90 and CD45 (Santa 
Cruz, USA) in a dilution of 1:100 at 4°C 
overnight. After washing, Flourochrome 
conjugated secondary antibody (FITC-rabbit anti 
goat) was added in each well. The cells were 
incubated with DAPI for 15 minutes rinsed with 
PBS, finally stained cells were observed under 
imaging station for expression analysis. 
Population doublings 
After every passage, cells were placed in a T25-
flask, 80-90% confluent cells were trypsinized, 
counted and replated. This phenomena was 
repeated until passage 7. Population doubling was 
calculated using an online population doubling 
calculator. (<http://www.doubling-time.com/
compute.php>).  
Treatment with CRC plasma 
The WJMSCs were plated in a 6 well tissue culture 
plates in equal number and divided in six groups. 
One of the groups was CRC patients’ plasma. Cells 
treated with DMEM and 10% colorectal cancer 
patients’ plasma. Several test was done on cells 
including cells viability assay, cell proliferation 
assay, LDH assay, ELISA, oxidative stress, 
cryopreservation of stem cells, and statistical 
analysis. LDH assay and ELISA, the protocol was 
the same mentioned above. The oxidative stress 
protocol was resemble to the protocol of GSH, 
Catalase, SOD and MDA which were mentioned 
above.   
During the cell viability assay, Cells after treatment 
were provided with crystal violet for 20 minutes 
which were subsequently lyesd with DMSO after 
three washings with normal saline. Absorbance was 
taken at 540 nm. 
Cell proliferation assay compare proliferative 
potential of all treatment cells. 3-(4, 5-
dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium 
bromide (MTT) assay was performed. Cells 
monolayer was first washed with PBS. 500 µl 10% 
complete medium and 60 µl MTT solution was 
added to cells and incubated for 2 hours. Cells were 
lysed with 1.5ml DMSO and absorbance was taken 
at 570 nm. 
Cryopreservation of stem cells 
The cells in the growth phase were detached from 
the surface by 1X trypsin EDTA and centrifuged at 
2000rpm for 10 minutes at 25˚C to obtain all the 
cells in pellet. Supernatant was discarded and pellet 
was suspended in 1ml plasma, 5µl heparin and 
DMSO (5%) 50µl. The cell suspension was saved 
in cryovials and stored at -200C for 2 hours then 
placed in -800C and then in liquid nitrogen for use 
in future. 
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Statistical analysis 
All experiments were performed in triplicates. 
Statistical tests and graphical representations were 
performed using GraphPad Prism 5 software 
(GraphPad, San Diego, CA). Data is presented as 
mean± standard deviation. Unpaired student T tests 
were performed for comparison between two 
group’s data Student’s t-test was used for 
comparison of data between two groups while 
ANOVA was performed for comparison between 
more than two groups. The statistical significance 
was set at P<0.05. 
Results 
LDH assay 
Cytotoxicity level was assessed in normal and 
different cancer patients’ plasma by the LDH assay. 
It was observed that plasma from normal persons, 
released a significantly less LDH as compared to all 
cancer patients. 
Sandwich ELISA  
Sandwich ELISA was performed on normal and 
different cancer plasma. Pro-apoptotic genes BAX 
was significantly decreased in all cancers plasma in 
comparison to normal plasma (Fig. 2A), while 
significantly increased gene expression of pro-
survival markers BCL2 was observed in all cancer 
group (Fig. 2B), whereas, p38 was significantly 
enhanced in all cancers (Fig. 2C), furthermore 
significant increased gene expression in all cancer 
group was observed in p53 tumor suppressor gene 
(Fig. 2D). 
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Fig. 1. Assessment of LDH release on normal and cancer patients’ plasma.  LDH release was significantly high in plasma from cancer 
patients. The data is expressed as mean ± SD and P≤0.05 was considered significant for all comparisons. *** denotes significant differ-
ence between normal and cancer groups. 
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Fig. 2. Graphical representation of ELISA for A)BAX, B)BCL2, C)P38 and D)P53 on normal and cancer serum. The data is ex-
pressed as mean ± SD and P<0.05 was considered significant for all comparisons. 
Oxidative stress 
Oxidative stress was assessed by comparing plasma 
of normal and different cancer groups. It was 
observed that GSH release was increased in CRC 
(Fig. 3A), SOD levels were significantly decreased 
in all cancer except CRC and OC (Fig. 3B) whereas, 
in catalase assay no significant difference between 
was observed between normal and OC while 
significant high expressed was found in other cancer 
groups (Fig. 3C) and significant high (P<0.05) 
MDA level was observed in all cancer (Fig. 3D). 
Isolation and culturing of WJMSCS 
The next step in the study was isolation and 
characterization of MSCs from WJ. The piece or 
explant after mincing released rounded cells in 
medium which attained mesenchymal appearance 
and flask got confluent after 15-20 days. 
Characterization of WJMSCs 
The WJMSCs were characterized for the expression 
of mesenchymal marker CD90 and hematopoietic 
marker CD45. WJMSCs expressed CD90 while they 
lack the expression of CD45. 
Evaluation of population doubling time 
The cells after every passage were collected to count 
the cell number. Estimation of population doublings 
rate of WJMSCs more accurately assesses the cells’ 
growth at different passages. 
Cells viability assay 
Cell viability was assesses by staining the cells with 
dye known as crystal violet. The dye stained all the 
cells present in a particular well and on lyses 
absorbance of the color released was compared for 
the all treatment groups. It was observed that cells 
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cultured in normal plasma are more viable than 
those cultured in different cancer plasma. 
Cell proliferation assay 
WJMSCs were treated with normal and different 
cancer patients’ plasma and were analyzed for cell 
proliferation by MTT assay. It was observed that 
cells cultured in cancer plasma showed a 
significantly low proliferation as compared to the 
control group. (Fig. 9A). 
LDH ASSAY 
LDH assay was performed on WJMSCs treated 
with normal and cancer plasma. LDH release was 
significantly higher in the medium of cells treated 
with cancer plasma. (Fig. 9B) 
Sandwich ELISA 
ELISA was performed on WJMSCs treated with 
normal and cancer plasma.  
Oxidative stress 
Oxidative stress was performed on WJMSCs 
treated with normal and different cancer plasma. It 
was observed that GSH release was significantly 
lower in medium of cells cultured with plasma of 
different cancer patients (Fig. 11A). Superoxide 
dismutase (SOD) release was significantly lower 
by the cells cultured in plasma of cancer patients as 
compared to untreated cells (Fig. 11B). Catalase 
release by cells of cancer plasma treated group was 
significantly lower as compared to normal 
untreated group as shown by less absorbance (Fig. 
11C). MDA release by cells of cancer plasma 
treated group was significantly higher as compared 
to normal untreated group as shown by less 
absorbance (Fig. 11D). 
 
Fig. 3. Graph representing effect of normal and cancer patient’s serum on A) glutathione B) SOD C) catalase and D) MDA release. 
The data is expressed as mean ± SD. 
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Fig. 4. Isolation and culturing of human WJMSCs (A) ~2 inches piece of umbilical cord was taken in a petri dish and washed with PBS. 
(B&C&D) The umbilical cord (UC) was minced into fine pieces. (E&F) WJ was obtained by removing the cord vessels and the amniotic 
epithelium, the thick jelly obtained was plated in culture flasks with DMEM and 10% Plasma. The cells were then placed in a humidified 
incubator. 
Fig. 5. Morphological appearance of WJMSCs. (A) Spherical Cells emerging from piece of cord was observed under microscope. (B) 
Digested material yielded small spherical cells at day 5. (C) Adhered cells formed mesenchymal extensions at day 10. (D) After 19 days 
of culture, the primary WJMSCs reached 80–90% confluency.  
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Fig. 6. Characterization of WJMSCS by Immunocytochemistry. 
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Fig. 7. Estimation of the population doubling level of WJMSCs. Population doublings shows an increase in growth rate of WJMSCs 
during 3-5 passages. 
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Fig. 8. WJMSCs treated with crystal violet to stain viable cells. (A) Comparison of cells viability on normal and cancer treated WJMSCs. 
(B) Graphical representation of cells viability of normal and cancer treated WJMSCs. The data is expressed as mean ± SD and P<0.05 
was considered significant for all comparisons. *** denotes significant difference between normal and different cancer group. 
. 
Fig. 9. A) Graph representing proliferative potential of WJMSCs treated with normal and cancer plasma. MTT cell proliferation assay 
revealed an increased rate of proliferation potential in normal cells as compared to cancer treated WJMSCs. B) Assessment of LDH as-
say on WJMSCs treated with normal and cancer plasma.  The data is expressed as mean ± SD and P<0.05 was considered significant for 
comparison.  
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Fig. 10. Graph showing effect of BAX, BCL2, P38 and P53 on WJMSCs treated with normal and cancer plasma. A. Pro-apoptotic genes 
BAX expression was significantly decreased in WJMSCs treated with cancers plasma in comparison to WJMSCs treated with normal 
plasma. B. Increased gene expression of pro-survival markers BCL2 was observed in cancer group. C. p38 kinase expression was de-
creased in CRC. D. Significant increased gene expression in cancer group was observed in p53 tumor suppressor gene. The data is ex-
pressed as mean ± SD and P<0.05 was considered significant for all comparisons.  
Fig. 11. Graph showing comparison of effect of WJMSCs treated with normal and cancer plasma’s on A) Glutathione B) SOD C) Cata-
lase D) MDA release. The data is expressed as mean ± SD and P<0.05 was considered significant for all comparisons. ** denotes signifi-
cant difference between normal and cancer group 
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Discussion 
The present study describes the potential behavior 
of WJMSCs in different cancers which was 
assessed by culturing these cells in plasma 
received from different cancer patients. One of the 
cancers was CRC. Before utilizing the plasma for 
the study, it was tested for 18 different hematology 
parameters, oxidative stress and paracrine factors 
like BAX, BCL2, p38, and p53. WJMSCs were 
effectively isolated from normal human umbilical 
cords and characterized for mesenchymal behavior 
preceding their culturing in plasma from cancer 
patients at passage 3. It was observed that cells 
cultured in plasma of cancer patients show 
decrease in cells’ survival rate and proliferation 
while high LDH leakage indicated an increased 
cells death and a marked oxidative stress was also 
observed.Higher levels of LDH indicates acute or 
chronic cell damage in the blood. In present study, 
a significant increase in LDH release in CRC 
patient’s plasma was observed. It has been 
documented that higher LDH levels was 
demonstrated colorectal cancer (Fig. 1) (22). Pro-
apoptotic protein Bax regulate apoptosis (23).  
Loss of function of Bax has been linked to 
tumorigenesis (24).  Bcl2 and Bax are involved in 
regulation of apoptosis, in cancer cells (25). In 
present study a significantly underexpression of Pro
-apoptotic Bax protein was observed in CRC plasma 
by ELISA (Fig. 2A).  
Apoptosis is known to plays a key role in normal or 
cancerous cells. Bcl2 is the most main regulators of 
apoptosis (23). Bcl-2 is the major anti-apoptotic 
protein, but over expression of Bcl2 leads to cancer 
cells over proliferation (25). Increase in Bcl2 levels 
appear to be more important for cell survival than 
the down-regulation of Bax (26). In present study, a 
significantly increased gene expression of pro-
survival markers bcl-2 was observed by ELISA in 
CRC group (Fig. 2B). 
The p38 MAP kinases, has been involved in 
complex biologic process, including proliferation, 
migration and death (27). Increased levels of  
activated p38 indicate poor prognosis (28).  
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In present study a significantly high expression of 
p38 protein was observed in CRC plasma by 
ELISA (Fig. 2C). 
Mutations are commonly observed genetic 
abnormalities in the tumor suppressor gene p53
(29). Cancer patients have higher risk of being p53 
antibody positive in comparison to healthy normal
(30). In present study a significantly high increased 
gene expression in CRC was observed in p53 
tumor suppressor gene (Fig. 2D). 
Cancer cells generate Reactive oxygen species 
(ROS) (31). ROS promote damage to the DNA 
producing mutations and formation of tumors (32). 
In tumor cells, the expression of glutathione (GSH) 
in tumor cells has been assessed as a prognosticator 
for the prognosis. GSH, an antioxidant enzyme that 
prevents damage to important cellular components 
induced by ROS. It has been reported that (GSH) 
levels in comparison to normal had significantly 
reduced in CRC (33). In our study, it was observed 
that GSH release was raised in CRC (Fig. 3A). 
Recent studies show that SOD levels was 
significantly decreased in CRC (34). However, in 
our study we didn’t observe this decreasing (Fig. 
3B).  
Catalase is an enzyme which is common in living 
organisms. It is responsible in conversion of 
hydrogen peroxide to oxygen and water (35).  It 
has been reported that the levels of catalase 
significantly reduced in colorectal cancer.  In 
present study, catalase levels was significantly high 
in CRC (Fig.3C). 
Malonedialdehyde (MDA) is a type of ROS 
produced as a result of lipid peroxidation. It has 
been reported in previous studies that MDA 
concentrations were higher in CRC which is 
according to our findings (Fig. 3D). 
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Next step was to isolate, culture and 
characterization of the stem cells from Wharton’s 
jelly of human umbilical cord (WJMSCs) leading 
to their culturing in plasma of colorectal cancer 
patients and other cancers.  
Stem cells were successfully isolated from human 
umbilical cord tissue following explant method. 
Cells when freed from pieces of cord afterwards 
adhered to the plastic surface forming 
mesenchymal extensions (Fig. 4 & 5). After that 
the isolated cells were characterized for 
mesenchymal stem cells behavior. Cells were 
found to be positive for MSC marker CD90 and 
negative for hematopoietic marker CD45 (Fig. 6). 
These results were according to the previous 
studies(28, 36). Faster doubling time is a common 
feature for MSCs derived from fetal blood, cord 
blood, and Wharton’s jelly (37). The isolated cells 
presented nearly constant rate of population 
doubling till passage eight and a regular increase in 
the population size (Fig. 7).  
These cells at passage 3 were provided with 
plasma of colorectal cancer and healthy people 
plasma in same percentage i.e.10% for 3 days. 
Rate of cell survival, proliferation and cell death 
were estimated by crystal violet staining, MTT 
assay and LDH release respectively while 
different paracrine factors like BAX, BCL2, p38, 
and p53 were estimated by ELISA. Oxidative 
stress and its enzymes were also analyzed in the 
study. 
Staining dye known as Crystal violet was used to 
assess cell viability. It was observed that cells 
cultured in normal plasma were more viable than 
those cultured in different cancer plasma (Fig. 8). 
MTT cell proliferation assay revealed a 
significantly reduced cell proliferation rate in all 
cancer treated cells compared to healthy plasma 
treated cells (Fig. 9A). 
LDH assay was performed on WJMSCs treated 
with normal and different cancer plasma. LDH 
release was significantly high in the medium of 
cells treated with cancer plasma (Fig. 9B). 
ELISA was performed on WJMSCs treated with 
normal and different cancer plasma. A significant 
decreased expression of BAX was expressed in 
WJMSCS treated with cancer plasma (Fig. 10a). 
An increased expression of pro-survival markers 
BCL-2 was expressed cancer treated WJMSCs 
(Fig. 10b). Whereas, p38 kinase expression was 
significantly decreased in colorectal cancer (Fig. 
10c). Significant increased gene expression in 
CRC was observed in p53 tumor suppressor gene 
(Fig.10d). 
Oxidative stress was performed on WJMSCs 
treated with normal and different cancer plasma. 
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It was observed that GSH release was 
significantly lower in medium of cells cultured 
with plasma from cancer patients (Fig. 11A). 
Superoxide dismutase (SOD) release was 
significantly lower by the cells cultured in 
plasma of cancer patients as compared to 
untreated cells (Fig. 11B). Catalase release by 
cells of cancer plasma treated group was 
significantly higher as compared to normal 
untreated group as shown by less absorbance 
(Fig. 11C). MDA release by cells of cancer 
plasma treated group was significantly higher as 
compared to normal untreated group (Fig. 11D). 
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Conclusion 
The present study demonstrates that WJMSCs can be isolated and cultured effectively in a large number. When 
cultured in plasma from colorectal cancer patients these cells show reduced viability, proliferation and 
increased apoptosis. For the future, certain measures should be taken to improve viability of WJMSCs in 
cancer conditions.   
